Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats
about
Renal dopaminergic system: Pathophysiological implications and clinical perspectivesG Protein-Coupled Receptor Kinases: Crucial Regulators of Blood PressureAccessory proteins for heterotrimeric G-proteins in the kidneyTempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic ratsHuman GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cellsDopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.Renal dopamine receptors, oxidative stress, and hypertension.Gender-based differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years.G protein-coupled receptor kinases: more than just kinases and not only for GPCRsGRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesityRenal dopamine and angiotensin II receptor signaling in age-related hypertension.Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.The Role of Aldosterone in Obesity-Related Hypertension.Inhibitory effect of the D(3) dopamine receptor on insulin receptor expression and function in vascular smooth muscle cells.G protein-coupled receptor kinase 4: role in blood pressure regulationImpaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats.G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance.Potential dopamine-1 receptor stimulation in hypertension management.The connection between GRKs and various signaling pathways involved in diabetic nephropathy.Dopamine and renal function and blood pressure regulation.Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice.Gastrointestinal-Renal Axis: Role in the Regulation of Blood PressureInsulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C.Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways.G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine
P2860
Q22241156-88AF8B18-DB33-4BCD-A1AD-96903072D936Q26743885-0C933680-DD1D-4E41-86E9-FB618ADA6402Q26795505-23CDFBAC-0AC4-4F0B-8F64-F97FAA16E813Q28582338-0D51AE57-4524-4EF0-9FFA-2E97633808D1Q30277906-C0A1F94E-8C61-4227-960A-8D0A02ED5EB7Q30300484-F2A8D35F-8D6A-4020-9B10-426842CC6B93Q30414139-18713DD8-F761-4BEA-8E3F-836C34A043AFQ30429420-2AB67D0C-8A50-41E3-A9B4-947435B60566Q34367267-38657161-DD78-44AE-8D35-7EE22D7BC761Q35175219-7F9E767A-0769-4053-84CA-41B0834F1471Q35621624-8DEFC407-3254-4575-B3FF-8C2A50B15276Q35694915-7701B87B-806A-45DF-8D6B-D38277FF4688Q35757227-08CAF31A-2A3D-48EB-A0DA-F4737FE213BFQ36527864-5CC31D9F-C41A-45F7-9E17-CE4BD3B58706Q36772839-DE4CFF72-0822-4700-9EB1-FD848896854AQ36950174-717F8F9A-A8F4-4C40-AAD4-3F7A63CA2E45Q37043602-B9838F23-FE5C-474B-B479-C2B5CAF1738FQ37043623-DB47E266-218F-4DFC-BBB3-66CEBA9F3C30Q37609291-73A1258F-EBCA-495C-8B25-660A8671BF5FQ37880070-574203C1-B404-445E-A9F6-EE8CA2E6FFD6Q37883978-AF20E418-7854-4D5F-94CA-DAEB566C433CQ37986493-D6F81B9B-9F37-4A45-B3CA-28DD5A7044BBQ38111703-5C41DFD1-FF70-46B2-823A-081E8DF25383Q38335202-5F3B7831-872A-4B2D-980B-36DF7EC9F65AQ39164330-3E9CB999-B3B6-49DA-BB1E-DBD66108340FQ40120084-3F9730D7-4B0F-460B-A73B-03C1A54CC988Q53128566-B634765E-2EFD-4E70-ABF7-E2D6E4F71716Q58651692-64B1BBD8-B28D-4B98-B58C-413B6BBC54A2
P2860
Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/08/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/08/01)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@ast
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@en
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@nl
type
label
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@ast
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@en
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@nl
prefLabel
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@ast
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@en
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@nl
P2860
P3181
P1476
Rosiglitazone restores renal D ...... rphosphorylation in obese rats
@en
P2093
Meghna Trivedi
Mustafa F. Lokhandwala
P2860
P304
P3181
P356
10.1152/AJPRENAL.00362.2004
P577
2005-08-01T00:00:00Z